Acinetobacter baumannii is frequently associated with nosocomial infections, and its increasing resistance to carbapenems may significantly reduce the choice of effective antibiotics ([2][1]). Since the first description of a carbapenem-hydrolyzing class D β-lactamase (CHDL), ARI-1 (renamed OXA-23
No takes yet. Share an insight, caveat, or question.
Girlich et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: